Book a Meeting

Anti-S. epidermidis LTA Antibody, Highly Galactosylated (BioBet-GA-435ZP) (CAT#: BioBet-GA-435ZP) Datasheet

Target
S. epidermidis LTA
Isotype
IgG1, κ
Description
Anti-S. epidermidis LTA Antibody, Highly Galactosylated (BioBet-GA-435ZP) is a chimeric IgG1, κ antibody against S. epidermidis LTA which contains with a high level of galactosylation.
Antibody Indication
Staphylococcal sepsis in infants with low birth weight
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced S. epidermidis LTA antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
S. epidermidis LTA
Alternative Names
Pagibaximab; 595566-61-3; BSYX-A110; A110; HU96-110; Lipoteichoic acid; LTA; S. epidermidis LTA; Staphylococcus epidermidis lipoteichoic acid
Cellular Localization
Extracellular region or secreted
Genecards
6709
Involvement in Disease
Its related pathways are Apoptosis Modulation and Signaling and NF-KappaB Family Pathway.
Related Pathways
A trimeric cytokine that binds to TNFRSF1A/TNFR1, TNFRSF1B/TNFBR and TNFRSF14/HVEM. It binds to TNFRSF3/LTBR in the form of heterotrimer with LTB. Lymphotoxins are produced by lymphocytes and are cytotoxic to a variety of tumor cells in vivo and in vitro.
Function
Cell Biology and Cellular Response antibody; Developmental Biology antibody; Neuroscience antibody; Signaling Transduction antibody
Field of research
Phosphorylation at Ser-416 inhibits enzymatic activity.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1, κ
Antibody Clone
BioBet-GA-435ZP
Host
Chimeric
Species Reactivity
S. epidermidis IgG1, κ
Description
The Highly Galactosylated Anti-S. epidermidis LTA (Pagibaximab), a biobetter antibody contains with a high level of galactosylation.
Antibody Indication
Staphylococcal sepsis in infants with low birth weight

Staphylococcal sepsis in infants with low birth weight

Related Products

Anti-S. epidermidis LTA Antibody, Recycling (AES-0622-ZP324) (CAT#: AES-0622-ZP324)
Anti-S. epidermidis LTA Antibody, On-Target (AES-0622-ZP980) (CAT#: AES-0622-ZP980)
Anti-S. epidermidis LTA Antibody, Half-Life Extended (AES-0622-ZP1308) (CAT#: AES-0622-ZP1308)
Anti-S. epidermidis LTA Antibody, FcγRIIB Binding Enhanced (AES-0622-ZP652) (CAT#: AES-0622-ZP652)
Anti-S. epidermidis LTA Antibody, Non-Fucosylated (BioBet-435ZP) (CAT#: BioBet-435ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.